Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McCann

Showing results (551-560 of 630) with videos related to

Pageof 63
Sort By:
Journal of Cardiovascular Development and Disease|May 26, 2023
Impact of the Remission of Type 2 Diabetes on Cardiovascular Structure and Function, Exercise Capacity and Risk Profile: A Propensity Matched AnalysisJoanna M Bilak, Jian L Yeo, Gaurav S Gulsin, et al.
Diabetes, Obesity & Metabolism|March 12, 2020
A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetesDavid R Webb, Zin Zin Htike, Daniel J Swarbrick, et al.
Journal of the American College of Cardiology|December 21, 2013
Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathyChristopher A Miller, Jaydeep Sarma, Josephine H Naish, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 12, 2020
Male sex adversely affects the phenotypic expression of diabetic heart diseaseLavanya Athithan, Amrit Chowdhary, Daniel Swarbrick, et al.
European Heart Journal. Cardiovascular Imaging|November 20, 2025
Accelerated stress CMR for the detection of significant coronary artery disease: a prospective randomized diagnostic accuracy studyMohamed Elshibly, Simran Shergill, Anju Velvet, et al.
BMC Cardiovascular Disorders|January 3, 2024
Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 DiabetesEmer M Brady, Thong H Cao, Alastair J Moss, et al.
Cardiovascular Research|February 18, 2020
Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trialDavid Corcoran, Aleksandra Radjenovic, Ify R Mordi, et al.
Diabetes Care|March 30, 2020
Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point TrialGaurav S Gulsin, Daniel J Swarbrick, Lavanya Athithan, et al.
The Lancet. Primary Care|December 26, 2025
Health inequalities and trends in heart failure diagnosis in primary care in England, 2000-21: a national retrospective cohort data-linkage studyClaire A Lawson, Mohammad R Ali, Gerry P McCann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 22, 2013
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and designDamian J Kelly, Gerald P McCann, Daniel Blackman, et al.
Pageof 63

Showing results (551-560 of 630) with videos related to

Sort By:
Pageof 63
Journal of Cardiovascular Development and Disease|May 26, 2023
Impact of the Remission of Type 2 Diabetes on Cardiovascular Structure and Function, Exercise Capacity and Risk Profile: A Propensity Matched AnalysisJoanna M Bilak, Jian L Yeo, Gaurav S Gulsin, et al.
Diabetes, Obesity & Metabolism|March 12, 2020
A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetesDavid R Webb, Zin Zin Htike, Daniel J Swarbrick, et al.
Journal of the American College of Cardiology|December 21, 2013
Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathyChristopher A Miller, Jaydeep Sarma, Josephine H Naish, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 12, 2020
Male sex adversely affects the phenotypic expression of diabetic heart diseaseLavanya Athithan, Amrit Chowdhary, Daniel Swarbrick, et al.
European Heart Journal. Cardiovascular Imaging|November 20, 2025
Accelerated stress CMR for the detection of significant coronary artery disease: a prospective randomized diagnostic accuracy studyMohamed Elshibly, Simran Shergill, Anju Velvet, et al.
BMC Cardiovascular Disorders|January 3, 2024
Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 DiabetesEmer M Brady, Thong H Cao, Alastair J Moss, et al.
Cardiovascular Research|February 18, 2020
Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trialDavid Corcoran, Aleksandra Radjenovic, Ify R Mordi, et al.
Diabetes Care|March 30, 2020
Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point TrialGaurav S Gulsin, Daniel J Swarbrick, Lavanya Athithan, et al.
The Lancet. Primary Care|December 26, 2025
Health inequalities and trends in heart failure diagnosis in primary care in England, 2000-21: a national retrospective cohort data-linkage studyClaire A Lawson, Mohammad R Ali, Gerry P McCann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 22, 2013
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and designDamian J Kelly, Gerald P McCann, Daniel Blackman, et al.
Pageof 63